Table 1.
Clinical and neuropathological information
| Patient | Gender | Age (years) | Cause of death | Postmortem delay (h) | Braak stage | CERAD stage | Neuropsychological diagnosis |
|---|---|---|---|---|---|---|---|
| AB1 | Male | 45 | Lung cancer | <1 | NA | NA | NA |
| AB2 | Female | 53 | Pulmonary shock | 4 | NA | NA | NA |
| IF10 | Male | 66 | Bronchopneumonia plus cardiac failure | 2 | NA | NA | NA |
| M16 | Male | 40 | Traffic accident | 3 | NA | NA | NA |
| M17 | Male | 36 | Bronchopneumonia | 2.5 | NA | NA | NA |
| IF1 | Female | 80 | – | 2 | IV | B | No evidence of cognitive impairment and dementia |
| IF2 | Female | 94 | Pulmonary tuberculosis | 1.5 | V | C | Dementia |
| IF6 | Male | 85 | Pneumonia | 2 | III | A | Mild cognitive impairment |
| VK11 | Female | 87 | Respiratory inflammation | 1.5 | III−IV | A | Dementia |
| VK22 | Female | 86 | – | 2 | V | C | Dementia |
Braak Stages (Braak and Braak, 1991): III (NFTs in entorhinal cortex and closely related areas); III-IV (NFTs abundant in amygdala and hippocampus. Extending slightly into association cortex); V-VI (NFTs widely distributed throughout the neocortex and ultimately involving primary motor and sensory areas). CERAD Stages (Mirra et al., 1991): A (Low density of neuritic plaques); B (Intermediate density of neuritic plaques); C (High density of neuritic plaques). NA: Not applicable; NFTs: neurofibrillary tangles. – : Not available.